| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |